Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
This study has been terminated.
(Gallium is no longer available for the conduct of this study.)
Sponsor:
Loyola University
Collaborator:
Genta Incorporated
Information provided by (Responsible Party):
Loyola University
ClinicalTrials.gov Identifier:
NCT00836173
First received: February 3, 2009
Last updated: October 29, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | May 2012 |
| Primary Completion Date: | May 2012 (Final data collection date for primary outcome measure) |